Arrowhead Research Corporation (ARWR) is a publicly traded Healthcare sector company. As of July 5, 2026, ARWR trades at $83.99 with a market cap of $11.83B and a P/E ratio of -39.06. ARWR moved +4.38% today. Year to date, ARWR is +24.89%; over the trailing twelve months it is +396.98%. Its 52-week range spans $9.57 to $84.55. Analyst consensus is strong buy with an average price target of $89.25. Rallies surfaces ARWR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ARWR combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $83.99 |
| Market Cap | $11.83B |
| P/E Ratio | -39.06 |
| EPS | $-2.15 |
| Dividend Yield | 0.00% |
| 52-Week High | $84.55 |
| 52-Week Low | $9.57 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $622.01M |
| Net Income | $-271.86M |
| Gross Margin | 0.00% |
9 analysts cover ARWR: 0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $89.25.